Clinical trial
The Individualized Management With Pegasys and Ribavirin Offering Viral Eradication (IMPROVE) Trial
NCT00483938 is registered in ClinicalTrials.gov with Hoffmann-La Roche as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Individualized Management With Pegasys and Ribavirin Offering Viral Eradication (IMPROVE) Trial
- Lead sponsor
- Hoffmann-La Roche
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- June 30, 2007
- Completion date
- May 31, 2010
- Enrollment
- 236 (actual)
- Sites
- 23
Conditions
As the registry lists them; a condition with its own page is linked.